Monthly Archives: March 2022
Has the Time Come to Say Goodbye to Therapeutic Drug Monitoring As We Know It?
The need for the SERENE studies of high-dose adalimumab induction therapy was clear. From the first randomized controlled trial evaluating the efficacy and safety of adalimumab for the management Crohn’s disease, CLASSIC-I trial, we were confident abou… Continue reading
WOMEN ARE DISADVANTAGED DURING DECEASED DONOR LIVER TRANSPLANT ALLOCATION: STRATEGIES TO OVERCOME INEQUITIES
Trying to Be American: A personal reflection of the pervasiveness of systemic racism and possible steps to mitigate its impact.
Food insecurity complicates diet-based therapy for gastrointestinal diseases
Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 years of Longitudinal Follow-up.
Symptoms of common mental disorders, such as anxiety or depression, are common in inflammatory bowel disease (IBD) and may affect prognosis. However, unlike clinical or biochemical markers of disease activity, psychological health is not a recommended … Continue reading
Rio de Janeiro Global Consensus on Landmarks, Definitions and Classifications in Barrett’s Esophagus: World Endoscopy Organization Delphi Study
Despite the significant advances made in the diagnosis and treatment of Barrett’s esophagus (BE), there is still a need for standardized definitions, appropriate recognition of endoscopic landmarks, and consistent use of classification systems. Current… Continue reading